APL-581

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameAPL-581
Drug Alias NameAPL-581OHM-581
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionBromodomain-containing protein 4 inhibitorsJanus kinase inhibitors
TargetsBromodomain-containing protein 4Janus kinase
Therapy Area/IndicationsHematologic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAptose Biosciences Inc
China Registration ClassN/A

Develop Information

Active CompaniesAptose Biosciences IncOhm oncology Inc
Inactive CompaniesN/A
Active IndicationsHematologic Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A